Intact Genomics

Executive Summary

Intact Genomics is an ISO 13485:2016 certified biotechnology company based in St. Louis, Missouri, that provides high-quality enzymes, competent cells, and molecular biology kits for DNA/RNA amplification, cloning, and gene editing. Founded in 2013, the company also offers custom genomic services and has developed proprietary platforms for capturing and expressing large DNA fragments. Serving over 2,000 labs worldwide, Intact Genomics supports research in human health, agriculture, and environmental science. Although the company is private and has not disclosed funding or valuation, its established customer base and ISO certification suggest a reliable operational track record. The company's focus on enabling genomic research positions it well in a growing market, but its lack of publicly available financials and limited news flow make it a lower-conviction opportunity.

Upcoming Catalysts (preview)

• TBDLaunch of Next-Generation Gene Editing Kits60% success
• TBDExpansion of Custom Genomic Services70% success
• TBDPartnership with Large Research Institutions50% success